Author information:
(1)OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam 
Jackson Park Road, LBRB 513, Portland, OR 97239, USA; Howard Hughes Medical 
Institute, Portland, OR 97239, USA; Division of Hematology and Medical Oncology, 
Oregon Health & Science University, Portland, OR 97239, USA.
(2)Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Room 
4280, Salt Lake City, UT 84112, USA.
(3)OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam 
Jackson Park Road, LBRB 513, Portland, OR 97239, USA; Division of Hematology and 
Medical Oncology, Oregon Health & Science University, Portland, OR 97239, USA.
(4)Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Room 
4280, Salt Lake City, UT 84112, USA; Department of Hematology, Nanfang Hospital, 
Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
(5)Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
(6)ARUP Laboratories, Salt Lake City, UT 84108, USA.
(7)OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam 
Jackson Park Road, LBRB 513, Portland, OR 97239, USA; Portland VA Health Care 
System, Portland, OR, USA; Department of Cell, Developmental, & Cancer Biology, 
Oregon Health & Science University, Portland, OR 97239, USA.
(8)OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam 
Jackson Park Road, LBRB 513, Portland, OR 97239, USA; Department of Cell, 
Developmental, & Cancer Biology, Oregon Health & Science University, Portland, 
OR 97239, USA.
(9)Service d'Hematologie Adulte, INSERM UMR 1160, Hospital Saint-Louis, 75010 
Paris, France.
(10)Laboratory of Hematology, University Hospital Saint-Louis, AP-HP and EA3518, 
University Paris Diderot, Paris, France.
(11)Leukemia Research Institute, The Catholic University of Korea, Seoul, 
Republic of Korea; Department of Hematology, Seoul St Mary's Hospital, The 
Catholic University of Korea, Seoul, Republic of Korea.
(12)Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Room 
4280, Salt Lake City, UT 84112, USA; Division of Hematology and Hematologic 
Malignancies, University of Utah, Salt Lake City, UT 84112, USA.
(13)OHSU Knight Cancer Institute, Oregon Health & Science University, 3181 SW 
Sam Jackson Park Road, LBRB 513, Portland, OR 97239, USA; Howard Hughes Medical 
Institute, Portland, OR 97239, USA; Division of Hematology and Medical Oncology, 
Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: 
drukerb@ohsu.edu.
(14)Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Room 
4280, Salt Lake City, UT 84112, USA; Division of Hematology and Hematologic 
Malignancies, University of Utah, Salt Lake City, UT 84112, USA. Electronic 
address: michael.deininger@hci.utah.edu.